Idarucizumab Journal Articles

authors

• Eikelboom, John
• Quinlan, Daniel J
• van Ryn, Joanne
• Weitz, Jeffrey

status

• published 

publication date

• December 2015

has subject area

• 1102 Cardiorespiratory Medicine and Haematology (FoR)
• 1103 Clinical Sciences (FoR)
• 1117 Public Health and Health Services (FoR)
• Animals (MeSH)
• Antibodies, Monoclonal, Humanized (MeSH)
• Antidotes (MeSH)
• Antithrombins (MeSH)
• Cardiovascular System & Hematology (Science Metrix)
• Clinical Trials, Phase I as Topic (MeSH)
• Dabigatran (MeSH)
• Hemorrhage (MeSH)
• Humans (MeSH)
• Protein Structure, Tertiary (MeSH)

published in

• Circulation  Journal

keywords

• Animals
• Antibodies, Monoclonal, Humanized
• Antidotes
• Antithrombins
• Clinical Trials, Phase I as Topic
• Dabigatran
• Hemorrhage
• Humans
• Protein Structure, Tertiary
• anticoagulant
• dabigatran
• hemorrhage
• idarucizumab

Digital Object Identifier (DOI)

• 10.1161/circulationaha.115.019628

PubMed ID

• 26700008

start page

• 2412

end page

• 2422

volume

• 132

issue

• 25